------------------------ Yahoo! Groups Sponsor --------------------~-->
Get fast access to your favorite Yahoo! Groups. Make Yahoo! your home page
http://us.click.yahoo.com/dpRU5A/wUILAA/yQLSAA/H4xqlB/TM
--------------------------------------------------------------------~->

Worldwide Biotech & Pharmaceutical Obtains the China Patent Golden
Medal For Its 'Intact Hepatitis C Virus (HCV) and Method for
Culturing HCV in Vitro by Cell Culture'

Marks the Highest Award Over the Past 10 Years in the Biomedical
Sciences
Industry in China

XI'AN, China, Aug. 25 -- Worldwide Biotech &
Pharmaceutical Company (OTC Bulletin Board: WWBP) (''WWBP'') has
obtained the
China Patent Golden Medal for ''the Intact Hepatitis C Virus (HCV)
and Method
for Culturing HCV in Vitro by Cell Culture.''
The project ''The Intact Hepatitis C Virus (HCV) and Method for
Culturing
HCV in vitro by Cell Culture'' was awarded the Chinese Patent by
China Patent
Bureau on October 23rd, 2002. The patent was then awarded the
prestigious
China Patent Golden Medal (Chinese Patent No. 01124001.6) in the 8th
China
Patent Assessment organized by both General World Intellectual
Property
Organization (WIPO) and the China Patent Office. Importantly, this
patent was
recognized by the World Intellectual Property Organization (WIPO),
issued as
an outstanding Chinese Patented Invention, and was the highest award
issued
for achievements in the biomedical sciences industry over the past
10 years in
China.
''We are highly encouraged with our patent which is recognized
by the WIPO
and it is such a great achievement for the whole company. It's a
great
milestone,'' said WenXia Guo, CEO and President of WWBP, ''the
success of this
patented invention leads our company to a worldwide market, we will
continue
our development and research of new inventions and bring health to
every
customer.''

About World Intellectual Property Organization (WIPO)
The World Intellectual Property Organization (WIPO) is an
international
organization dedicated to promoting the use and protection of works
of the
human spirit. These works -- intellectual property -- are expanding
the
bounds of science and technology and enriching the world of the
arts. Through
its work, WIPO plays an important role in enhancing the quality and
enjoyment
of life, as well as creating real wealth for nations. With
headquarters in
Geneva, Switzerland, WIPO is one of the 16 specialized agencies of
the United
Nations system of organizations. It administers 23 international
treaties
dealing with different aspects of intellectual property protection.

About Worldwide Biotech & Pharmaceutical Company
Worldwide Biotech & Pharmaceutical Co. (''WWBP'') is a hi-tech
biotech
company with top-ranking pharmaceutical R&D abilities, Good
Manufacturing
Practices (GMP) licensed manufacturing facilities and a well-
established
marketing network in China and Southeast Asia. The product range of
WWBP
covers Hepatitis C Virus (HCV) products, diagnostic medicines and
Over-The-Counter (OTC) drugs. WWBP currently possesses 35,940
square meters
of land and 5,359 square meters of GMP standard facilities. With
strong
pharmaceutical R&D abilities especially in the HCV field, WWBP has
been known
as the first biotech company in the world to hold the technology of
culturing
intact HCV in vitro by cell culture.
WWBP has achieved a GMP production scale level of 10,000 ml for
concentrated HCV material and 10 grams HCV antigen per month, which
is
expected to bring WWBP considerable gross sale revenue each year and
greatly
strengthen the company's R&D on anti-HCV drug screen and HCV human
vaccine.
WWBP had successfully reached two Memoriam of Understanding of Merger
Agreements with pharmaceutical companies in China, all of which have
scalable
production and well-established sales networks, and the acquiring is
expected
to be finished before the end of September 2005. The acquisitions
will
strengthen WWBP's R&D abilities and production scale, as well as
extend its
marketing network throughout China and Southeast Asia. WWBP has
been working
closely with pharmaceutical research institutes, and has established
connections with both central & local governments.

Safe Harbor
Information in this news release may contain statements about
future
expectations, plans, prospects or performance of Worldwide Biotech &
Pharmaceutical Co. that constitute forward-looking statements for
purposes of
the safe harbor provisions under the Private Securities Litigation
Reform Act
of 1995. The words or phrases "can be," "expects," "may
affect," "believed,"
"estimate," "project," and similar words and phrases are intended to
identify
such forward-looking statements. Worldwide Biotech & Pharmaceutical
Co.
cautions you that any forward-looking information provided by or on
behalf of
Worldwide Biotech & Pharmaceutical Co. is not a guarantee of future
performance. None of the information on this website constitutes an
offer to
sell securities or investment advice of any kind, and visitors
should not base
their investment decisions on information contained in this website.
Worldwide
Biotech & Pharmaceutical Co.'s actual results may differ materially
from those
anticipated in such forward-looking statements as a result of various
important factors, some of which are beyond Worldwide Biotech &
Pharmaceutical
Co.'s control. In addition to those discussed in Worldwide Biotech &
Pharmaceutical Co.'s press releases, public filings, and statements
by
Worldwide Biotech & Pharmaceutical Co.'s management, including, but
not
limited to, Worldwide Biotech & Pharmaceutical Co.'s estimate of the
sufficiency of its existing capital resources, Worldwide Biotech &
Pharmaceutical Co.'s ability to raise additional capital to fund
future
operations, Worldwide Biotech & Pharmaceutical Co.'s ability to
repay its
existing indebtedness, the uncertainties involved in estimating
market
opportunities and, in identifying contracts which match Worldwide
Biotech &
Pharmaceutical Co.'s capability to be awarded contracts. All such
forward-looking statements are current only as of the date on which
such
statements were made. Worldwide Biotech & Pharmaceutical Co. does
not
undertake any obligation to publicly update any forward-looking
statement to
reflect events or circumstances after the date on which any such
statement is
made or to reflect the occurrence of unanticipated events.

SOURCE Worldwide Biotech & Pharmaceutical Company

http://www.arizonabiotech.com/
http://groups.yahoo.com/group/biotech-news/
http://www.arizonaentrepreneurs.com/
http://www.azhttp.com/
http://www.arizonabiotech.com/index.php
http://www.mail-archive.com/biotech-news@yahoogroups.com/
http://www.mail-archive.com/biotech-
news@yahoogroups.com/maillist.html

http://www.arizonabiotech.com/
<a href="http://www.arizonabiotech.com/">Arizona Biotech</a>
http://groups.yahoo.com/group/biotech-news/
<a href="http://groups.yahoo.com/group/biotech-news/">Biotech News</a>
http://www.arizonaentrepreneurs.com/
<a href="http://www.arizonaentrepreneurs.com/">Arizona Entrepreneurs</a>
http://www.azhttp.com/
<a href="http://www.azhttp.com/">Arizona High Tech</a>

Yahoo! Groups Links

<*> To visit your group on the web, go to:
http://groups.yahoo.com/group/biotech-news/

<*> To unsubscribe from this group, send an email to:
biotech-news-unsubscribe@yahoogroups.com

<*> Your use of Yahoo! Groups is subject to:
http://docs.yahoo.com/info/terms/

Arizona Biotech

Biotech News

Arizona Entrepreneurs

Arizona High Tech